Log in to save to my catalogue

CD11c⁺CD88⁺CD317⁺ myeloid cells are critical mediators of persistent CNS autoimmunity

CD11c⁺CD88⁺CD317⁺ myeloid cells are critical mediators of persistent CNS autoimmunity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8040603

CD11c⁺CD88⁺CD317⁺ myeloid cells are critical mediators of persistent CNS autoimmunity

About this item

Full title

CD11c⁺CD88⁺CD317⁺ myeloid cells are critical mediators of persistent CNS autoimmunity

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2021-04, Vol.118 (14), p.1-11

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Natalizumab, a humanized monoclonal antibody (mAb) against α4-integrin, reduces the number of dendritic cells (DC) in cerebral perivascular spaces in multiple sclerosis (MS). Selective deletion of α4-integrin in CD11c⁺ cells should curtail their migration to the central nervous system (CNS) and ameliorate experimental autoimmune encephalomyelitis (...

Alternative Titles

Full title

CD11c⁺CD88⁺CD317⁺ myeloid cells are critical mediators of persistent CNS autoimmunity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8040603

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8040603

Other Identifiers

ISSN

0027-8424,1091-6490

E-ISSN

1091-6490

DOI

10.1073/pnas.2014492118

How to access this item